Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Go back to Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.25 -0.03 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.28 | 52 Week High | $19.75 | |||
| Open | $13.93 | 52 Week Low | $4.26 | |||
| Day High | $14.81 | P/E | N/A | |||
| Day Low | $13.93 | EPS | $0.00 | |||
| Volume | 5,963,108 | |||||
